Capitalizing on Hope: Questionable Marketing Approval and Pricing of a New ALS Drug

Regulatory agencies must balance patient demands to access new treatments for fatal diseases with limited treatment options while ensuring drug safety and efficacy. However, questionable U.S. regulatory actions resulted in the early approval of AMX0035 to treat amyotrophic lateral sclerosis (ALS) by...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of social determinants of health and health services (Print) 2024-10, Vol.54 (4), p.405-411
Hauptverfasser:	Flynn, Matthew B., Flynn, James F., Palacios, Ana M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!